TRIPLEXAM Trademark

Trademark Overview

On Thursday, October 7, 2010, a trademark application was filed for TRIPLEXAM with the United States Patent and Trademark Office. The USPTO has given the TRIPLEXAM trademark a serial number of 79089170. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, October 7, 2020. This trademark is owned by BIOFARMA. The TRIPLEXAM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular diseases
triplexam

General Information

Serial Number79089170
Word MarkTRIPLEXAM
Filing DateThursday, October 7, 2010
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, October 7, 2020
Registration Number3964646
Registration DateTuesday, May 24, 2011
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, March 8, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular diseases
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 29, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBIOFARMA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party NameBIOFARMA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party NameBIOFARMA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Tuesday, March 22, 2022UNDELIVERABLE MAIL - NO ACTION TAKEN
Saturday, November 27, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Saturday, November 27, 2021DEATH OF INTERNATIONAL REGISTRATION
Saturday, December 15, 2018TOTAL INVALIDATION PROCESSED BY THE IB
Monday, September 10, 2018TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, September 10, 2018INVALIDATION PROCESSED
Wednesday, August 29, 2018TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, December 29, 2017CANCELLED SECTION 71
Saturday, December 3, 2011CHANGE OF NAME/ADDRESS REC'D FROM IB
Sunday, October 2, 2011NOTIFICATION PROCESSED BY IB
Thursday, August 4, 2011FINAL DISPOSITION NOTICE SENT TO IB
Thursday, August 4, 2011FINAL DISPOSITION PROCESSED
Thursday, June 23, 2011GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, May 24, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, March 8, 2011PUBLISHED FOR OPPOSITION
Thursday, March 3, 2011NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, March 3, 2011NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 16, 2011NOTICE OF PUBLICATION
Monday, January 10, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 7, 2011ASSIGNED TO EXAMINER
Saturday, December 4, 2010APPLICATION FILING RECEIPT MAILED
Tuesday, November 30, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 29, 2010LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, November 25, 2010SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

triplexam diseases cardiovascular treatment preparations pharmaceutical